• MOLECULAR PHARMACOLOGY HOME

    Welcome to the Molecular Pharmacology Division of ASPET. The division is actively involved in developing programming and sponsoring symposia and colloquia at the Annual meetings of ASPET at Experimental Biology. We also sponsor other meetings of interest to Molecular Pharmacology Division members. On this website you will find information on activities, Student and Postdoctoral awards, and the people involved in governing the division and more.


    Recent News and Announcements...

  • 2012 Election Results
    Tesmer_Ostrom

    John J. Tesmer, Associate Research Scientist at the Life Sciences Institute of the University of Michigan, has been elected Chair Elect of the Division for Molecular Pharmacology.  Rennolds S. Ostrom, Associate Professor in the Department of Pharmacology at the University...

    GRS and GRC in Phosphorylation

    Registration for the 2012 Gordon-Kenan Research Seminar (GRS) and Gordon Research Conference (GRC) in Phosphorylation and G-Protein Mediated Signaling is now open.

    The Mol Pharm Division likes to party in 3D

    2011 Party in 3D

    View a slideshow of candid photos of the EB 2011 MolPharm meeting...

    2011 Student and Postdocoral Awards

    2011 Grad Student Poster Group (small)The Molecular Pharmacology Division congratulates the 2011 winners of the annual Postdoctoral Best Abstract Competition and Graduate Student Best Abstract Competition, presented at the Experimental Biology meeting in Washington, D.C....

  • About the Division...

    The ASPET Division for Molecular Pharmacology serves members applying approaches of biochemistry, biophysics, genetics, and molecular biology to study molecular mechanisms of drug action, regardless of the class of drug. Areas of interest include (but are not limited to): drug receptor-effector coupling and its regulation (e.g. receptor- structure and function, G proteins, kinases, phosphatases, and second messenger synthesis and degradation), voltage- and ligand-gated ion channels, antimicrobial and antineoplastic drug action, steroid and growth factor receptors, gene regulation, and identification of molecular targets for drugs.